Predicting Clinical Outcomes in Helicobacter pylori-positive Patients using Supervised Learning through the Integration of Demographic and Genomic Features
V NarasimhaniD, Sreya Pulakkat WarrieriD, Jobin Jacob John, Monisha Priya T., Niriksha Varadaraj, Greeshma Grace Thomas, Balaji VeeraraghavaniD
Abstract
BackgroundHelicobacter pylori (H. pylori) infection is widespread globally and is linked to outcomes ranging from chronic gastritis to gastric cancer. However, only a minority of infected individuals progress to malignancy, influenced by a mix of bacterial, host, and environmental factors. Current predictive approaches are limited due to relying mainly on clinical and lifestyle data. Genomic approaches have been sparsely used, and thus their incorporation into machine learning models could ensure early and personalized detection. This study aimed to evaluate the impact of integrating host metadata with genomic features from H. pylori to predict gastric cancer outcomes and identify associated variables. Methods1,363 publicly available H. pylori genomes with associated host information between 1991 and 2024 were collected from NCBI and EnteroBase. Demographic features, virulence genes, sequence-derived and variant-based features were extracted. Machine learning models were then developed to classify infection outcomes into gastric cancer and non-gastric cancer. Logistic regression, an interpretable baseline model, was compared against higher-performance ensemble models (XGBoost, Random Forest). Model performance was assessed using recall, precision, AUROC, and AUPRC curves. ResultsThe logistic regression model achieved a recall of 0.736 (95% CI: 0.644-0.831) for gastric cancer and an AUROC of 0.888 (95% CI: 0.843-0.929). Both XGBoost and Random Forest models outperformed the baseline model with AUROC values ranging from 0.950-0.954 (95% CI: 0.904-0.976). Black-box model recall for gastric cancer detection improved compared to the baseline by 8.3% for XGBoost (0.797, 95% CI: 0.711-0.877), and 11.4% for Random Forest (0.820, 95% CI: 0.734-0.896). Across models, patient age consistently emerged as the strongest predictor of gastric cancer, with several sequence-derived genomic features beyond pre-established virulence genes contributing to the infection outcome differences. ConclusionThis study demonstrates that combining pathogen genomics with host demographics uncovers novel risk factors and ensures early detection with high predictive power. The use of explainability methods like SHAP allows for greater interpretability by clinical professionals and improves informed decision-making processes. Validation and translation into clinical practice can be carried out with broader, diverse datasets along with the inclusion of additional host and lifestyle variables.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 6.31
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Decoding Helicobacter pylori Resistance: Machine Learning Enhanced Prediction of Antibiotic Susceptibility using Whole-Genome Sequencing
Florent Ailloud, Diyuan Lu, … Sebastian Suerbaum·bioRxiv·Aug 7, 2025
- The gatekeeper to gastric cancer; gastric microbiota invade the lamina propria in Helicobacter pylori-associated gastric carcinogenesis
Harriet J. Giddings, Ana Teodòsio, … Amanda E. Rossiter·HelicobacterPeer-reviewed·Jan 1, 2025
- Increased H. pylori stool shedding and EPIYA-D cagA alleles are associated with gastric cancer in an East Asian hospital
S. Talarico, C. Leverich, … N. R. Salama·bioRxiv·Mar 20, 2018
- Genome-wide association study of gastric cancer- and duodenal ulcer-derived Helicobacter pylori strains reveals discriminatory amino acid differences and novel oncoprotein candidates
K. Yahara, V. P. Tuan, … Y. Yamaoka·bioRxiv·Mar 15, 2021
- A Genetic and Immunohistochemical Analysis of H. Pylori Phenotypes and p27 expression in Adenocarcinoma Patients in Jordan
S. A. Al-sheboul, A. A. A.-R. Mohammad, … I. Matalka·bioRxiv·Dec 18, 2022
- Helicobacter pylori accelerates KRAS-dependent gastric dysplasia
V. P. O'Brien, A. Koehne, … N. Salama·bioRxiv·Oct 6, 2020